Ultragenyx Pharmaceutical Inc (RARE)
43.30
+0.76
(+1.79%)
USD |
NASDAQ |
May 01, 16:00
43.27
-0.03
(-0.07%)
Pre-Market: 20:00
Ultragenyx Pharmaceutical Accounts Payable (Quarterly): 42.11M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 42.11M |
September 30, 2023 | 33.36M |
June 30, 2023 | 42.12M |
March 31, 2023 | 58.98M |
December 31, 2022 | 43.27M |
September 30, 2022 | 23.53M |
June 30, 2022 | 34.21M |
March 31, 2022 | 23.68M |
December 31, 2021 | 17.14M |
September 30, 2021 | 15.58M |
June 30, 2021 | 21.79M |
March 31, 2021 | 15.74M |
December 31, 2020 | 12.92M |
September 30, 2020 | 10.85M |
June 30, 2020 | 9.014M |
March 31, 2020 | 14.40M |
December 31, 2019 | 12.87M |
September 30, 2019 | 13.46M |
June 30, 2019 | 8.743M |
March 31, 2019 | 12.66M |
December 31, 2018 | 12.28M |
September 30, 2018 | 8.198M |
Date | Value |
---|---|
June 30, 2018 | 10.31M |
March 31, 2018 | 7.569M |
December 31, 2017 | 8.886M |
September 30, 2017 | 9.288M |
June 30, 2017 | 11.88M |
March 31, 2017 | 8.345M |
December 31, 2016 | 5.364M |
September 30, 2016 | 6.616M |
June 30, 2016 | 6.954M |
March 31, 2016 | 6.012M |
December 31, 2015 | 2.942M |
September 30, 2015 | 4.422M |
June 30, 2015 | 10.17M |
March 31, 2015 | 5.755M |
December 31, 2014 | 4.857M |
September 30, 2014 | 4.161M |
June 30, 2014 | 3.59M |
March 31, 2014 | 3.495M |
December 31, 2013 | 1.437M |
September 30, 2013 | 2.89M |
December 31, 2012 | 1.20M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
8.743M
Minimum
Jun 2019
58.98M
Maximum
Mar 2023
23.88M
Average
17.14M
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
Corcept Therapeutics Inc | 17.40M |
Madrigal Pharmaceuticals Inc | 28.04M |
Sarepta Therapeutics Inc | 164.92M |
FibroGen Inc | 17.96M |
Rocket Pharmaceuticals Inc | -- |